Drug Channels Archive for February, 2026

Click a link below to view the mailing archive as if it had been sent to you.

2026-02-27 07:47		Drug Channels - Beyond DTP 2.0: How Flexible Direct-to-Patient Programs Power Best-In-Class Patient Experiences
2026-02-24 07:47		Drug Channels News Roundup, February 2026: Mark Cuban on FTC-ESI, What Patients Really Want, QALYs vs. MFN, 340B's Site of Care Shift, and New Faces at DCI
2026-02-20 07:47		Drug Channels - The State of Patient Access: What Industry Leaders Reveal in a New Survey About Hub Models, Technology, and the Road Ahead
2026-02-18 07:47		Drug Channels - Medicare Part D Pharmacy Networks in 2026: Supermarkets Dominate as Drugstores Stall and Independents Walk Away
2026-02-13 07:47		Drug Channels - The Key to a Better Patient Experience: Improved GTN
2026-02-10 07:47		Drug Channels - Copay Accumulators and Maximizers in 2025: Popular, Profitable, and Problematic
2026-02-06 07:47		Drug Channels - In an Uncertain 340B Environment, Kalderos Offers a Clear Path Forward
2026-02-04 14:15		Drug Channels - The FTC Blows Up Express Scripts' PBM Model—and Launches the Net Pricing Drug Channel
2026-02-03 07:47		Drug Channels - Latest CMS Data Reveal Six Trends Reshaping U.S. Drug Spending